Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...

This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.

Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Shares of Cencora Inc. COR advanced 1.82% to $253.54 Friday, on what proved to be an all-around favorable trading session for ...

Cencora, Inc. (NYSE:COR – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten analysts ...

In early January, the company formerly known as AmerisourceBergen, which owns and operates Besse Medical, purchased Retina ...

Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company ...